Mounjaro savings card: eligibility, price and self-pay (2026)

The Mounjaro savings card at a glance

Lilly’s Mounjaro savings card has two tiers. Which one applies depends on whether your commercial plan covers Mounjaro. Every figure below is as shown on Lilly’s Mounjaro savings page on Oct 19, 2026. Programs change; confirm on Lilly’s site before you fill.

The card covers the single-dose pen. The current US label lists four presentations: single-dose pen, single-dose vial, multi-dose vial and single-patient-use KwikPen (DailyMed, Aug 27, 2026). The savings terms we reviewed name only the single-dose pen (Eli Lilly, Oct 19, 2026).

How the Mounjaro caps work

Both annual caps line up exactly with 13 fills at the monthly maximum. For a covered plan, 13 × $150 = $1,950. For a plan that does not cover Mounjaro, 13 × $647 = $8,411. So the yearly limit is the monthly cap applied to every fill the card allows.

The worked examples below are our arithmetic on the published caps. They are not quotes from Lilly, and your plan’s actual copay sets the result.

The last row shows the edge of the not-covered tier: $499 plus the $647 cap is $1,146. A 1-month cash price above that would leave you paying more than $499. The third row shows the same edge for a covered plan: a copay above $175 for a 1-month fill leaves more than $25 to pay.

The tirzepatide cost calculator totals a schedule over any number of weeks at a price you enter.

Which route fits which situation

This table maps what Lilly lists to common coverage situations. It is not a recommendation. Your formulary, prior authorization and deductible determine what you pay, and your pharmacist can run the card against your claim.

LillyDirect self-pay price for Mounjaro

On Oct 19, 2026, LillyDirect listed the Mounjaro single-dose pen at $499 a month for every strength (Eli Lilly, Oct 19, 2026). Unlike Zepbound self-pay pricing, the Mounjaro price does not step with the dose.

A flat price means a dose change does not change the self-pay cost.

Yearly cost at the listed prices

Monthly prices can hide the yearly total. This table multiplies the lowest listed price on each route by 13 fills, the card’s yearly fill limit. It is our arithmetic, not a Lilly figure, and it assumes every fill qualifies at the lowest price.

The not-covered card price and the LillyDirect self-pay price are the same $499 on the pages we reviewed. What differs is the mechanism: one is a card applied at a pharmacy, the other is a cash price through Lilly’s own service. The label escalates in 2.5 mg steps after at least 4 weeks on the current dose when more glycemic control is needed, up to 15 mg in adults (DailyMed, Aug 27, 2026). See the Mounjaro dosing schedule and the tirzepatide titration tool for the label ladder.

Mounjaro and Zepbound savings cards compared

Mounjaro and Zepbound both contain tirzepatide, but Lilly runs separate cards with different caps.

Zepbound also has a separate KwikPen card and dose-based self-pay prices. See the Zepbound savings card guide for those terms.

What Mounjaro is approved for

The current label lists two indications (DailyMed, Aug 27, 2026):

• As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes.
• To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk.

Lilly’s May 13, 2022 approval release stated that Mounjaro is not indicated for weight loss (Eli Lilly, May 13, 2022). Zepbound is the tirzepatide brand labeled for chronic weight management. The tirzepatide hub covers both brands.

The label lists six strengths for the single-dose pen: 2.5, 5, 7.5, 10, 12.5 and 15 mg, each in 0.5 mL (DailyMed, Aug 27, 2026).

Fine print worth reading before a fill

• Terms can change. Lilly states its program terms may be terminated, rescinded, revoked or amended at any time without notice (Eli Lilly, Oct 19, 2026).
• Government beneficiaries are excluded from both tiers (Eli Lilly, Oct 19, 2026).
• Single-dose pen only. The card applies to Mounjaro single-dose pen NDCs (Eli Lilly, Oct 19, 2026).
• GoodRx. We could not verify GoodRx’s Mounjaro page on Oct 19, 2026, so we report no GoodRx price for Mounjaro.
• Compounded tirzepatide is a different product. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed (FDA, Oct 1, 2026). Compounded products are not FDA approved and are not interchangeable with Mounjaro.

Storage rules differ by presentation; the tirzepatide storage tool lists the label limits. Talk to your prescriber or pharmacist about coverage, dose and presentation. This page reports program terms and does not recommend a route.